Skip to main content

Hybrid Operating Room Market | Philips Healthcare (The Netherlands), Siemens Healthineers (Germany), Stryker Corporation (U.S.) Key Players

The global hybrid operating room market is expected to grow at a CAGR of 12.5% between 2017 and 2022. Factors driving the growth of this market include the increasing adoption of minimally invasive surgical procedures and technological advancements among others.

As of 2016, Philips Healthcare (The Netherlands), Siemens Healthineers (Germany), Stryker Corporation (U.S.), Toshiba Corporation (Japan), GE Healthcare (U.S.), IMRIS Inc. (U.S.), Eschmann Equipment (U.K.), MAQUET GmbH (Germany), Trumpf Medical (Germany), and Skytron LLC (U.S.), Richard Wolf GmbH (Germany), MIZUHO OSI (U.S.), STERIS plc. (U.S.), NDS Surgical Imaging (U.S.), Alvo (Poland) are some of the major manufacturers in hybrid operating room market.

Analysis of the market developments between 2014 and 2017 (March) show that new product launch, agreements, and collaborations were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market position by collaborating to develop and provide technologically advanced products to its customer base. For instance, in 2017, Siemens Healthineers (Germany), received FDA clearance for its ARTIS pheno Angiography System.

Philips Healthcare is one of the leading players in the hybrid operating room market, in 2016. In order to strengthen its current position and to gain a larger share in the hybrid operating room market, the company aggressively focuses on inorganic and organic business growth strategies such as partnerships, product launches, approvals, and product deployment. In February 2017, Philips Healthcare launched Azurion, an image-guided therapy platform. Additionally, in January 2017, Philips launched its augmented-reality surgical navigation technology for spine, cranial, and trauma surgeries.

Labels:

Comments

Post a Comment

Popular posts from this blog

Best Accounting Software to Kick-start the Business for Smaller Firms – Xero

  Xero Accounting Software is an online software mainly designed for the accounting needs of small business firms. The software can be operated from a PC, phone, tablet, or Mac to view the cash flows of the company in real-time. The software is for small business houses and hence it is simple to use yet smart so that the users can devote most of the time in other important areas of their business. USP of This Software: Xero accounting software offers accounting services to small business firms in a smarter way. Some of the USPs of the software the more than 800apps integrated into the software, secure encryption, support system better performance report generation, and others apart from the basic accounting services offered. Best Accounting Software for Medium-Sized Businesses@ https://blog.360quadrants.com/2020/best-accounting-software-for-medium-sized-businesses/ Xero Pricing Xero accounting software offers 30 days of free trial after which you can choose from any of the pri...
Post a Comment
Read more

Cell Sorting Market

The global  cell sorting market  is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% in the forecast period (2016-2021). Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of market. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and RoW. Among the four geographic regions, North America is estimated to command the largest share of the market in 2016, foll...
Post a Comment
Read more

Risk-based Monitoring Software Market | Key Factor in Clinical Trial | Market Growth Worth $511 million

  Growth in the risk based monitoring software market can primarily be attributed to factors such as the cost and time efficiency of RBM solutions, rising number of clinical trials, and increasing government funding and grants to support clinical trials. However, the high implementation cost of RBM solutions is expected to restrain the growth of this market during the forecast period. RBM Software Market Dynamics: Impact Analysis 1. Increased outsourcing of clinical trial processes to CROs 2. Cost and time efficiency of RBM solutions 3. Increasing government funding and grants to support clinical trials 4. Increased pharmaceutical R&D spending 5. Initiatives to boost digital health to propel market growth The risk-based monitoring (RBM) software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3% Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102112429 Software Component: The sof...
Post a Comment
Read more